India, July 27 -- Gossamer Bio, Inc. (GOSS) announced that following a productive Pre-NDA Type B meeting with the U.S. FDA and receipt of the official meeting minutes, the company is moving forward wi... Read More
India, July 27 -- After showing a strong move to the upside early in the session, stocks have given back ground over the course of the trading day on Monday. The major averages have pulled back well o... Read More
India, July 27 -- Entera Bio Ltd. (ENTX), a clinical-stage biotechnology company developing oral peptide therapies, Monday announced a securities purchase agreement for an oversubscribed private place... Read More
India, July 27 -- Virtuix Holdings Inc. (VTIX), said on Monday that Tesla, Inc. (TSLA) purchased an Omni One Enterprise system for its Optimus humanoid robot program. On the Nasdaq, shares of Virtuix... Read More
India, July 27 -- Humacyte, Inc. (HUMA), a biotechnology company developing bioengineered human tissues, announced on Monday that the U.S. Food and Drug Administration (FDA) has accepted its Investiga... Read More
India, July 27 -- InnoCare Pharma (INCPF) announced that its novel TYK2 inhibitor, Fadeucravacitinib, achieved the primary endpoint in a registrational Phase III trial in patients with moderate-to-sev... Read More
India, July 27 -- Shares of Edible Garden AG Incorporated (EDBL) are climbing about 20 percent on Monday morning after it received a fresh cut herb distribution order from Walmart across the Mid-Atlan... Read More
India, July 27 -- Baker Hughes Company (BKR) shares climbed $4.70, or 8.21 percent, to $61.95 after the energy technology company reported late Sunday a sharp increase in second-quarter orders and exp... Read More
India, July 27 -- Shares of Forte Biosciences, Inc. (FBRX) jumped 40% on Monday morning after argenx (ARGX) agreed to acquire the clinical-stage biotechnology company in an all-cash deal valued at app... Read More
India, July 27 -- AstraZeneca's (AZN) rare disease unit, Alexion, has announced results from its Phase III program evaluating Ultomiris (ravulizumab) in patients with thrombotic microangiopathy after ... Read More